Neogenomics Income Statement (2010-2026) | NEO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	121.72M	121.34M	125.73M	117.17M	125.07M	128.78M	138.71M	137.22M	146.92M	151.95M	155.55M	156.24M	164.50M	167.82M	172.00M	168.03M	181.33M	187.80M	190.17M	186.67M
Cost of Revenue (Quarter)	17.22M	74.10M	250.59M	16.30M	17.07M	79.89M	17.14M	16.26M	18.90M	89.64M	-188.23M	90.77M	92.01M	92.94M	308.15M	22.68M	24.07M	107.35M	23.44M	105.81M
Gross Profit (Quarter)	52.99M	47.24M	45.26M	38.23M	43.95M	48.89M	56.83M	54.81M	59.89M	62.31M	67.59M	65.47M	72.49M	74.88M	77.26M	73.25M	77.26M	80.45M	83.34M	80.86M
Operating items
Research & Development (Quarter)	3.50M	7.41M	8.51M	7.71M	8.63M	7.31M	6.67M	7.39M	7.50M	5.29M	7.13M	7.62M	7.89M	7.68M	7.97M	10.18M	9.02M	8.69M	9.18M	9.53M
Selling, General & Administrative (Quarter)	54.64M	63.84M	62.39M	66.25M	57.95M	64.28M	54.88M	61.55M	60.31M	61.49M	59.76M	65.80M	63.33M	66.97M	63.64M	68.21M	71.75M	69.87M	63.51M	65.74M
Restructuring Costs (Quarter)							4.52M	4.68M	3.07M	2.12M	1.21M	2.40M
Other Operating Expenses (Quarter)	17.22M	15.70M	15.92M	16.30M	17.07M	16.81M	17.14M	16.26M	18.90M	17.61M	18.07M	20.22M	23.22M	21.42M	24.05M	22.68M	44.12M	28.89M	24.07M	23.83M
Operating Expenses (Quarter)	75.36M	86.95M	86.82M	90.26M	83.65M	88.40M	83.21M	89.89M	89.78M	86.51M	86.16M	96.04M	94.44M	96.08M	95.66M	101.07M	124.89M	107.46M	96.76M	99.11M
Operating Income (Quarter)	-22.37M	-39.71M	-41.57M	-52.03M	-39.70M	-39.51M	-26.38M	-35.07M	-29.89M	-24.20M	-18.57M	-30.57M	-21.94M	-21.20M	-18.40M	-27.82M	-47.63M	-27.01M	-13.41M	-18.24M
EBIT (Quarter)	-22.37M	-39.71M	-41.57M	-52.03M	-39.70M	-39.51M	-26.38M	-35.07M	-29.89M	-24.20M	-18.57M	-30.57M	-21.94M	-21.20M	-18.40M	-27.82M	-47.63M	-27.01M	-13.41M	-18.24M
Non-operating items
Interest & Investment Income (Quarter)									4.31M	4.53M	4.84M	4.83M	4.59M	4.67M	4.33M	3.72M	2.26M	1.56M	1.52M	1.27M
Other Non Operating Income (Quarter)	0.17M	0.09M	-0.93M	0.17M	-0.41M	0.03M	-0.00M	-0.11M	0.73M	-0.10M	0.12M	-0.26M	-0.00M	0.32M	-0.43M	0.07M	0.48M	-0.34M	0.08M	-0.01M
Non Operating Income (Quarter)	0.17M	0.09M	-0.93M	0.17M	-0.41M	0.03M	-0.00M	-0.11M	0.73M	-0.10M	0.12M	-0.26M	-0.00M	0.32M	-0.43M	0.07M	0.48M	-0.34M	0.08M	-0.01M
Net income details
EBT (Quarter)	73.44M	-23.17M	-44.20M	-53.16M	-41.03M	-39.62M	-25.52M	-33.72M	-26.64M	-21.45M	-15.29M	-27.68M	-19.02M	-17.85M	-16.13M	-25.66M	-45.82M	-26.39M	-12.41M	-17.58M
Tax Provisions (Quarter)	-2.44M	-2.82M	-2.44M	-3.75M	-5.73M	-2.77M	-2.84M	-2.92M	-2.31M	-2.94M	-0.96M	-0.62M	-0.38M	-0.15M	-0.80M	0.27M	-0.72M	0.74M	-2.52M	-0.47M
Profit After Tax (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Income from Continuing Operations (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Consolidated Net Income (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Income towards Parent Company (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	75.87M	-20.35M	-41.76M	-49.41M	-35.30M	-36.85M	-22.69M	-30.80M	-24.33M	-18.52M	-14.33M	-27.06M	-18.64M	-17.70M	-15.32M	-25.92M	-45.09M	-27.13M	-9.88M	-17.11M
Additional items
EPS (Basic) (Quarter)	0.64	-0.17	-0.35	-0.40	-0.28	-0.30	-0.18	-0.25	-0.19	-0.15	-0.11	-0.21	-0.15	-0.14	-0.12	-0.20	-0.35	-0.21	-0.07	-0.13
EPS (Weighted Average and Diluted) (Quarter)	0.59	-0.17	-0.35	-0.40	-0.28	-0.30	-0.18	-0.25	-0.19	-0.15	-0.11	-0.21	-0.15	-0.14	-0.12	-0.20	-0.35	-0.21	-0.07	-0.13
Shares Outstanding (Weighted Average) (Quarter)	117.25M	122.56M	119.96M	123.63M	124.07M	124.06M	124.22M	125.03M	125.19M	125.69M	125.50M	126.11M	126.26M	126.95M	126.66M	127.38M	127.95M	128.41M	128.10M	129.17M
Shares Outstanding (Diluted Average) (Quarter)	131.24M	122.56M	119.96M	123.63M	124.07M	124.42M	124.22M	125.03M	125.19M	125.69M	125.50M	126.11M	126.41M	126.49M	126.66M	127.38M	127.95M	127.92M	128.10M	129.17M
EBITDA (Quarter)	-22.37M	-39.71M	-41.57M	-52.03M	-39.70M	-39.51M	-26.38M	-35.07M	-29.89M	-24.20M	-18.57M	-30.57M	-21.94M	-21.20M	-18.40M	-27.82M	-47.63M	-27.01M	-13.41M	-18.24M
Interest Expenses (Quarter)	0.90M	1.30M	4.84M	1.30M	0.93M	0.14M	5.21M	1.76M	1.78M	1.69M	1.68M	1.69M	1.67M	1.64M	1.62M	1.62M	0.93M	0.60M	0.60M	0.60M
Tax Rate (Quarter)	-3.32%	12.18%	5.53%	7.06%	13.96%	7.00%	11.12%	8.67%	8.67%	13.68%	6.28%	2.24%	1.97%	0.84%	4.99%	-1.04%	1.58%	-2.80%	20.35%	2.69%

Research Tools

Neogenomics Income Statement (2010-2026) | NEO

Create an account

Sign In

Reset Password